PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8953468-0	1996	Role of nitric oxide/cyclic GMP pathway in the inhibitory effect of GABA and dopamine on prolactin release.	Dopamine	77-85	5'-nucleotidase, cytosolic II	Homo sapiens	28-31	
13448-2	1976	Measurement of CSF cyclic GMP may allow evaluation of possible implications of the dopaminergic hyperactivity in schizophrenia proposed by the dopamine hypothesis.	Dopamine	83-91	5'-nucleotidase, cytosolic II	Homo sapiens	26-29	
15374750-1	2004	We showed previously, using in vitro microdialysis, that the activation of the soluble guanylate cyclase (sGC)/cyclic GMP pathway was the underlying mechanism of the extracellular Ca(2+)-dependent effects of exogenous NO on dopamine (DA) secretion from PC12 cells.	Dopamine	224-232	5'-nucleotidase, cytosolic II	Homo sapiens	118-121	
15374750-1	2004	We showed previously, using in vitro microdialysis, that the activation of the soluble guanylate cyclase (sGC)/cyclic GMP pathway was the underlying mechanism of the extracellular Ca(2+)-dependent effects of exogenous NO on dopamine (DA) secretion from PC12 cells.	Dopamine	234-236	5'-nucleotidase, cytosolic II	Homo sapiens	118-121	
10987848-12	2000	When they are low, DA concentrations are increased in a cyclic GMP-dependent manner and may act to facilitate Glu and GABA release further.	Dopamine	19-21	5'-nucleotidase, cytosolic II	Homo sapiens	63-66